Genomic profiling of malignant pleural mesothelioma with array‐based comparative genomic hybridization shows frequent non‐random chromosomal alteration regions including <i>JUN</i> amplification on 1p32

Cancer Science - Tập 98 Số 3 - Trang 438-446 - 2007
Tetsuo Taniguchi1, Sivasundaram Karnan, Takayuki Fukui, Toshihiko Yokoyama, Hiroyuki Tagawa, Kohei Yokoi, Yuichi Ueda, Tetsuya Mitsudomi, Yoshitsugu Horio, Toyoaki Hida, Yasushi Yatabe, Masao Seto, Yoshitaka Sekido
1Division of Molecular Oncology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, Japan

Tóm tắt

Genome‐wide array‐based comparative genomic hybridization analysis of malignant pleural mesotheliomas (MPM) was carried out to identify regions that display DNA copy number alterations. Seventeen primary tumors and nine cell lines derived from 22 individuals were studied, some of them originating from the same patients. Regions of genomic aberrations observed in >20% of individuals were 1q, 5p, 7p, 8q24 and 20p with gains, and 1p36.33, 1p36.1, 1p21.3, 3p21.3, 4q22, 4q34‐qter, 6q25, 9p21.3, 10p, 13q33.2, 14q32.13, 18q and 22q with losses. Two regions at 1p32.1 and 11q22 showed a high copy gain. The 1p32.1 region contained a protooncogene, JUN, and we further demonstrated overexpression of JUN with real‐time polymerase chain reaction analysis. As MPM cell lines did not overexpress JUN, our findings suggested that induction of JUN expression was involved in the development of MPM cells in vivo, which also might result in gene amplification in a subset of MPM. Meanwhile, the most frequent alteration was the 9p21.3 deletion, which includes the p16INK4a/p14ARF locus. With polymerase chain reaction analysis, we determined the extent of the homozygous deletion regions of the p16INK4a/p14ARF locus in MPM cell lines, which indicated that the deletion regions varied among cell lines. Our results with array comparative genomic hybridization analysis provide new insights into the genetic background of MPM, and also give some clues to develop a new molecular target therapy for MPM. (Cancer Sci 2007; 98: 438–446)

Từ khóa


Tài liệu tham khảo

10.3109/10408448209041321

Lanphear BP, 1992, Latent period for malignant mesothelioma of occupational origin, J Occup Med, 34, 718

10.1053/sonc.2002.30227

10.1016/j.currproblcancer.2004.04.001

10.1038/sj.bjc.6690105

10.1056/NEJMra050152

10.1002/ajim.20246

10.1200/JCO.1998.16.1.145

10.1200/JCO.20005.14.589

10.1200/JCO.2003.11.136

10.1016/0165-4608(86)90074-9

Popescu NC, 1988, Nonrandom chromosome alterations in human malignant mesothelioma, Cancer Res, 48, 142

10.1016/0165-4608(88)90035-0

10.1002/gcc.2870010207

10.1016/0165-4608(90)90258-C

Taguchi T, 1993, Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma, Cancer Res, 53, 4349

Lee WC, 1996, Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma, Cancer Res, 56, 4297

Bell DW, 1997, Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma, Cancer Res, 57, 4057

Cheng JQ, 1994, p16 alterations and deletion mapping of 9p21‐p22 in malignant mesothelioma, Cancer Res, 54, 5547

Xio S, 1995, Codeletion of p15 and p16 in primary malignant mesothelioma, Oncogene, 11, 511

Sekido Y, 1995, Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer, Cancer Res, 55, 1227

10.1073/pnas.92.24.10854

10.1002/(SICI)1097-4652(199908)180:2<150::AID-JCP2>3.0.CO;2-H

10.1111/j.1440-1843.2005.00694.x

Metcalf RA, 1992, p53 and Kirsten‐ras mutations in human mesothelioma cell lines, Cancer Res, 52, 2610

Papp T, 2001, Mutational analysis of N‐ras, p53, 16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas, Int J Oncol, 18, 425

Kumar K, 2005, Mutational analysis of 9 different tumour‐associated genes in human malignant mesothelioma cell lines, Oncol Rep, 14, 743

10.1111/j.1349-7006.2006.00184.x

10.1016/0165-4608(95)00358-4

10.1038/bjc.1997.91

10.1038/bjc.1998.42

Balsara BR, 1999, Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1‐15 in human malignant mesothelioma, Cancer Res, 59, 450

De Rienzo A, 2000, Recent advances in the molecular analysis of human malignant mesothelioma, Clin Ther, 151, 433

10.1002/path.1128

Sambrook J, 1989, Molecular Cloning: A Laboratory Manual.

10.1038/sj.onc.1208300

10.1038/2524

10.1158/0008-5472.CAN-03-3773

10.1002/gcc.20309

10.1158/0008-5472.CAN-03-4056

10.1093/nar/30.9.e36

10.1073/pnas.90.8.3299

Shivapurkar N, 1999, Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma, Clin Cancer Res, 5, 17

10.1038/sj.bjc.6690816

10.1093/carcin/21.5.1023

10.1007/s00428-005-0059-3

Angel P, 1991, The role of Jun, Fos and the AP‐1 complex in cell proliferation and transformation, Biochim Biophys Acta, 1072, 129

10.1200/JCO.2005.05.1458

10.1016/j.lungcan.2005.07.010

10.1016/S1389-1723(02)80201-8

10.1038/sj.onc.1206589

10.1002/gcc.10192

10.1002/gcc.20119

10.1038/sj.onc.1208263

10.1038/sj.onc.1204557

10.1038/sj.onc.1206533

Thông tin
Thông tin xuất bản

Cancer Science

Tập 98 Số 3

438-446

Thông tin tác giả